NWT Uranium PE Ratio 2010-2024 | CPTRF
Current and historical p/e ratio for NWT Uranium (CPTRF) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NWT Uranium PE ratio as of July 25, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| NWT Uranium PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2020-11-02 | 0.15 | 0.00 | |
| 2020-09-30 | 0.13 | $-0.28 | 0.00 |
| 2020-06-30 | 0.12 | $-0.46 | 0.00 |
| 2020-03-31 | 0.10 | $-0.65 | 0.00 |
| 2019-12-31 | 0.21 | $-1.26 | 0.00 |
| 2019-09-30 | 0.51 | $-1.12 | 0.00 |
| 2019-06-30 | 1.06 | $-0.93 | 0.00 |
| 2019-03-31 | 1.46 | $-0.99 | 0.00 |
| 2018-12-31 | 0.91 | $0.46 | 1.98 |
| 2018-09-30 | 44.00 | $0.53 | 83.02 |
| 2018-06-30 | 72.00 | $0.60 | 120.00 |
| 2018-03-31 | 74.00 | $0.40 | 185.00 |
| 2017-12-31 | 90.15 | $0.40 | 225.37 |
| 2017-09-30 | 0.60 | $0.40 | 1.50 |
| 2017-06-30 | 3.84 | $0.40 | 9.60 |
| 2017-03-31 | 1.40 | $0.80 | 1.75 |
| 2016-12-31 | 0.80 | 0 | 0.00 |
| 2016-09-30 | 0.72 | 0 | 0.00 |
| 2016-06-30 | 0.44 | 0 | 0.00 |
| 2016-03-31 | 0.52 | 0 | 0.00 |
| 2015-12-31 | 0.68 | 0 | 0.00 |
| 2015-09-30 | 0.64 | $-0.20 | 0.00 |
| 2015-06-30 | 1.42 | 0 | 0.00 |
| 2015-03-31 | 0.88 | 0 | 0.00 |
| 2013-12-31 | 1.80 | 0 | 0.00 |
| 2013-09-30 | 2.40 | 0 | 0.00 |
| 2013-06-30 | 4.80 | 0 | 0.00 |
| 2012-03-31 | 37.60 | 0 | 0.00 |
| 2011-12-31 | 33.20 | 0 | 0.00 |
| 2011-09-30 | 47.00 | $3.40 | 13.82 |
| 2011-06-30 | 60.40 | $3.20 | 18.88 |
| 2011-03-31 | 60.04 | $4.40 | 13.65 |
| 2010-12-31 | 88.00 | $6.00 | 14.67 |
| 2010-09-30 | 75.68 | $3.00 | 25.23 |
| 2010-06-30 | 73.72 | $2.40 | 30.72 |
| 2010-03-31 | 70.80 | $1.20 | 59.00 |
| 2009-12-31 | 44.40 | $-0.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.027B |
| Captor Capital Corp. is a vertically integrated cannabis company. It cultivates, manufacture and distribute recreational and medical marijuana based products to consumers through brands and dispensary retail stores. Captor Capital Corp., formerly known as NWT URANIUM CP, is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.593B | 25.64 |
| Boston Scientific (BSX) | United States | $157.132B | 37.53 |
| Stryker (SYK) | United States | $151.401B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $135.007B | 0.00 |
| Medtronic (MDT) | Ireland | $118.404B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.975B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.249B | 25.26 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.152B | 16.69 |
| Agilent Technologies (A) | United States | $34.187B | 22.29 |
| Terumo (TRUMY) | Japan | $25.999B | 33.77 |
| Koninklijke Philips (PHG) | Netherlands | $24.882B | 17.46 |
| Insulet (PODD) | United States | $20.168B | 79.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.166B | 12.31 |
| Baxter (BAX) | United States | $14.764B | 11.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.788B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.131B | 24.82 |
| Lantheus Holdings (LNTH) | United States | $4.907B | 12.38 |
| Perrigo (PRGO) | Ireland | $3.864B | 9.79 |
| Prestige Consumer Healthcare (PBH) | United States | $3.769B | 16.84 |
| Haemonetics (HAE) | United States | $3.568B | 16.25 |
| Envista Holdings (NVST) | United States | $3.503B | 29.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.180B | 23.45 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 40.79 |
| QuidelOrtho (QDEL) | United States | $1.781B | 12.25 |
| AtriCure (ATRC) | United States | $1.494B | 0.00 |
| Acuren (TIC) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.268B | 28.52 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.193B | 15.25 |
| Neogen (NEOG) | United States | $1.111B | 14.22 |
| BioLife Solutions (BLFS) | United States | $1.065B | 0.00 |
| InMode (INMD) | Israel | $0.918B | 9.25 |
| Kestra Medical Technologies (KMTS) | United States | $0.871B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.851B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.707B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.690B | 0.00 |
| Valneva SE (VALN) | France | $0.646B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.09 |
| CeriBell (CBLL) | United States | $0.556B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.458B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.311B | 11.44 |
| Cresco Labs (CRLBF) | United States | $0.311B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.271B | 80.17 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 20.97 |
| OraSure Technologies (OSUR) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| Biote (BTMD) | United States | $0.228B | 6.40 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Omeros (OMER) | United States | $0.210B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.202B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 15.52 |
| TriSalus Life Sciences (TLSI) | United States | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.34 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.70 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Safety Shot (SHOT) | United States | $0.085B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.92 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.036B | 49.14 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |